355 related articles for article (PubMed ID: 17680222)
21. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy.
Vicini FA; Keisch M; Shah C; Goyal S; Khan AJ; Beitsch PD; Lyden M; Haffty BG
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):512-8. PubMed ID: 22079730
[TBL] [Abstract][Full Text] [Related]
22. Partial breast irradiation in breast conserving therapy by way of intersitial brachytherapy.
Benitez PR; Chen PY; Vicini FA; Wallace M; Kestin L; Edmundson G; Gustafson G; Martinez A
Am J Surg; 2004 Oct; 188(4):355-64. PubMed ID: 15474426
[TBL] [Abstract][Full Text] [Related]
23. Objective and longitudinal assessment of dermatitis after postoperative accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy in patients with breast cancer treated with breast conserving therapy: reduction of moisture deterioration by APBI.
Tanaka E; Yamazaki H; Yoshida K; Takenaka T; Masuda N; Kotsuma T; Yoshioka Y; Inoue T
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1098-104. PubMed ID: 20932653
[TBL] [Abstract][Full Text] [Related]
24. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
Vicini F; Beitsch PD; Quiet CA; Keleher AJ; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer HM; Lyden M
Cancer; 2008 Feb; 112(4):758-66. PubMed ID: 18181095
[TBL] [Abstract][Full Text] [Related]
25. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
[TBL] [Abstract][Full Text] [Related]
26. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy.
Gómez-Iturriaga A; Pina L; Cambeiro M; Martínez-Regueira F; Aramendía JM; Fernández-Hidalgo O; Martínez-Monge R
Brachytherapy; 2008; 7(4):310-5. PubMed ID: 18778971
[TBL] [Abstract][Full Text] [Related]
27. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
28. MammoSite accelerated partial breast irradiation: a single-institution outcomes analysis with 2 years of followup.
Haley M; Beriwal S; Heron DE; Kim H; Falk J; Johnson R; Mogus R
Brachytherapy; 2009; 8(1):9-13. PubMed ID: 18955020
[TBL] [Abstract][Full Text] [Related]
29. Accelerated partial-breast irradiation vs conventional whole-breast radiotherapy in early breast cancer: a case-control study of disease control, cosmesis, and complications.
Wadasadawala T; Sarin R; Budrukkar A; Jalali R; Munshi A; Badwe R
J Cancer Res Ther; 2009; 5(2):93-101. PubMed ID: 19542664
[TBL] [Abstract][Full Text] [Related]
30. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis.
Shah NM; Tenenholz T; Arthur D; DiPetrillo T; Bornstein B; Cardarelli G; Zheng Z; Rivard MJ; Kaufman S; Wazer DE
Cancer; 2004 Aug; 101(4):727-34. PubMed ID: 15305402
[TBL] [Abstract][Full Text] [Related]
31. [Accelerated partial breast irradiation using interstitial high dose rate brachytherapy: preliminary clinical and dosimetric results after 61 patients].
Hannoun-Levi JM; Ferré M; Raoust I; Lallement M; Flipo B; Ettore F; Marcié S
Cancer Radiother; 2008 Nov; 12(6-7):532-40. PubMed ID: 18835737
[TBL] [Abstract][Full Text] [Related]
32. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience.
Harper JL; Jenrette JM; Vanek KN; Aguero EG; Gillanders WE
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):169-74. PubMed ID: 15629608
[TBL] [Abstract][Full Text] [Related]
33. Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
Vargo JA; Verma V; Kim H; Kalash R; Heron DE; Johnson R; Beriwal S
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):285-91. PubMed ID: 24268787
[TBL] [Abstract][Full Text] [Related]
34. Treatment volume and dose optimization of MammoSite breast brachytherapy applicator.
Dickler A; Kirk M; Choo J; Hsi WC; Chu J; Dowlatshahi K; Francescatti D; Nguyen C
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):469-74. PubMed ID: 15145164
[TBL] [Abstract][Full Text] [Related]
35. Late chest wall toxicity after MammoSite breast brachytherapy.
Brashears JH; Dragun AE; Jenrette JM
Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
[TBL] [Abstract][Full Text] [Related]
36. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results.
Cuttino LW; Keisch M; Jenrette JM; Dragun AE; Prestidge BR; Quiet CA; Vicini FA; Rescigno J; Wazer DE; Kaufman SA; Ramakrishnan VR; Patel R; Arthur DW
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):107-14. PubMed ID: 18037585
[TBL] [Abstract][Full Text] [Related]
37. Multicatheter hybrid breast brachytherapy: a potential alternative for patients with inadequate skin distance.
Beriwal S; Coon D; Kim H; Haley M; Patel R; Das R
Brachytherapy; 2008; 7(4):301-4. PubMed ID: 18771962
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes of APBI via multicatheter interstitial HDR brachytherapy: Results of a prospective single-institutional registry.
Gabani P; Cyr AE; Zoberi JE; Ochoa LL; Matesa MA; Thomas MA; Garcia J; Margenthaler JA; Naughton MJ; Ma C; Sanati S; Zoberi I
Brachytherapy; 2018; 17(1):171-180. PubMed ID: 29089275
[TBL] [Abstract][Full Text] [Related]
39. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
[TBL] [Abstract][Full Text] [Related]
40. Pilot study of sole conformal peroperative interstitial brachyradiotherapy of early stage breast carcinoma using high-dose rate afterloading.
Slampa P; Soumarova R; Ruzickova J; Chrenko V; Fait V; Bartlova R; Ticha H; Zaloudik J
Neoplasma; 2005; 52(4):292-6. PubMed ID: 16059644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
